TMO vs DGX
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Quest Diagnostics Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | DGX |
|---|---|---|
| Price | $700.22 | $259.60 |
| Market cap | $259.44B | $28.56B |
| P/E ratio | 36.9 | 25.9 |
| ROE | 13.38% | 15.32% |
| Profit margin | 14.94% | 9.54% |
| Revenue growth | 9.10% | 10.00% |
| Dividend yield | 0.27% | 1.33% |
| Beta | 0.84 | 0.55 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs DGX in plain English
- TMO is the bigger company — about 9.1× the market cap of DGX.
- DGX is cheaper on earnings (P/E 25.9 vs 36.9).
- DGX earns a higher return on equity (15% vs 13%).
- DGX is growing revenue faster (10% vs 9%).
- DGX has the higher dividend yield (1.33% vs 0.27%).
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
DGX return calculator
See what $1,000 in Quest Diagnostics Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.